Sonova (OTCMKTS:SONVY) Hits New 1-Year Low – Should You Sell?

Sonova Holding (OTCMKTS:SONVY)’s stock price reached a new 52-week low during trading on Monday . The company traded as low as $43.51 and last traded at $43.57, with a volume of 1633 shares trading hands. The stock had previously closed at $44.79.

Wall Street Analysts Forecast Growth

SONVY has been the subject of several recent analyst reports. BNP Paribas Exane raised shares of Sonova from a “strong sell” rating to a “strong-buy” rating in a report on Tuesday, March 10th. Zacks Research raised shares of Sonova from a “strong sell” rating to a “hold” rating in a research report on Monday, February 9th. Finally, Jefferies Financial Group cut shares of Sonova from a “hold” rating to a “moderate sell” rating in a report on Wednesday, March 18th. Two research analysts have rated the stock with a Strong Buy rating, one has given a Buy rating, four have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy”.

Sonova Price Performance

The company has a current ratio of 1.24, a quick ratio of 0.91 and a debt-to-equity ratio of 0.51. The stock’s 50-day moving average price is $52.03 and its 200 day moving average price is $53.21.

Sonova Company Profile

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.